Search research articles
Contact Us
Filters
Showing results (31-40 of 67) with videos related to
Page
of 7
Sort By:
Therapeutic Advances in Gastroenterology
|
August 27, 2025
Outcome of adding percutaneous transhepatic cholangial drainage to DEB-TACE in patients with unresectable cholangiocarcinoma with obstructive jaundice: comparison with sole DEB-TACE
Jiajia Xu, Chao Chen, Yanhua Ye, et al.
BMC Gastroenterology
|
April 21, 2021
Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study
Liangliang Yan, Yanqiao Ren, Kun Qian, et al.
BMC Cardiovascular Disorders
|
February 8, 2023
Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year's experience of clinical technique
Xiangjun Dong, Ziqian Peng, Yanqiao Ren, et al.
Journal of Hepatocellular Carcinoma
|
January 15, 2025
Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
Guilin Zhang, Yanqiao Ren, Jiayun Liu, et al.
Heliyon
|
June 12, 2024
The time window for pre-emptive transjugular intrahepatic portosystemic shunt could be extended to 5 days
Xiangjun Dong, Jiacheng Liu, Yaowei Bai, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
March 28, 2022
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
Yanqiao Ren, Yusheng Guo, Lei Chen, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
June 20, 2024
Ultrasmall Metal TPZ Complexes with Deep Tumor Penetration for Enhancing Radiofrequency Ablation Therapy and Inducing Antitumor Immune Responses
Licheng Zhu, Yanqiao Ren, Mengna Dong, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
October 4, 2021
Value of <sup>18</sup>F-FDG PET/MR Imaging in the Early Evaluation of Treatment Response following Radiofrequency Ablation of Liver Cancer in a Rabbit Model
Xuefeng Kan, Yanqiao Ren, Xin Li, et al.
Scientific Reports
|
April 7, 2022
The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus
Weihua Zhang, Linxia Wu, Lei Chen, et al.
Journal of Cancer Research and Therapeutics
|
June 1, 2020
Classification of hepatocellular carcinoma diameter by statistical technology and prognostic evaluation in patients after the combined use of transarterial chemoembolization and radiofrequency ablation
Yanyan Cao, Yanqiao Ren, Hong Ma, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 67) with videos related to
Sort By:
Page
of 7
Therapeutic Advances in Gastroenterology
|
August 27, 2025
Outcome of adding percutaneous transhepatic cholangial drainage to DEB-TACE in patients with unresectable cholangiocarcinoma with obstructive jaundice: comparison with sole DEB-TACE
Jiajia Xu, Chao Chen, Yanhua Ye, et al.
BMC Gastroenterology
|
April 21, 2021
Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study
Liangliang Yan, Yanqiao Ren, Kun Qian, et al.
BMC Cardiovascular Disorders
|
February 8, 2023
Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10 year's experience of clinical technique
Xiangjun Dong, Ziqian Peng, Yanqiao Ren, et al.
Journal of Hepatocellular Carcinoma
|
January 15, 2025
Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
Guilin Zhang, Yanqiao Ren, Jiayun Liu, et al.
Heliyon
|
June 12, 2024
The time window for pre-emptive transjugular intrahepatic portosystemic shunt could be extended to 5 days
Xiangjun Dong, Jiacheng Liu, Yaowei Bai, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
March 28, 2022
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma
Yanqiao Ren, Yusheng Guo, Lei Chen, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
June 20, 2024
Ultrasmall Metal TPZ Complexes with Deep Tumor Penetration for Enhancing Radiofrequency Ablation Therapy and Inducing Antitumor Immune Responses
Licheng Zhu, Yanqiao Ren, Mengna Dong, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
October 4, 2021
Value of <sup>18</sup>F-FDG PET/MR Imaging in the Early Evaluation of Treatment Response following Radiofrequency Ablation of Liver Cancer in a Rabbit Model
Xuefeng Kan, Yanqiao Ren, Xin Li, et al.
Scientific Reports
|
April 7, 2022
The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus
Weihua Zhang, Linxia Wu, Lei Chen, et al.
Journal of Cancer Research and Therapeutics
|
June 1, 2020
Classification of hepatocellular carcinoma diameter by statistical technology and prognostic evaluation in patients after the combined use of transarterial chemoembolization and radiofrequency ablation
Yanyan Cao, Yanqiao Ren, Hong Ma, et al.
Page
of 7